-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $8.5

Benzinga·03/18/2025 15:38:21
Listen to the news
Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $10.5 to $8.5.